# Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12

> **NCT01679223** · — · UNKNOWN · sponsor: **University of Nevada, Las Vegas** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01679223
- **Lead sponsor:** University of Nevada, Las Vegas
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01679223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01679223, "Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01679223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*